8-K

FDCTECH, INC. (FDCT)

8-K 2022-05-27 For: 2022-05-27
View Original
Added on April 06, 2026


UNITED

STATES

SECURITIES

AND EXCHANGE COMMISSION

WASHINGTON,

DC 20549

FORM

8-K

CURRENT

REPORT

Pursuant

to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Dateof Report: May 27, 2022

(Dateof earliest event reported)

FDCTECH,

INC.

(Exactname of registrant as specified in its charter)

Delaware 000-56338 81-1265459
(State or other jurisdiction<br><br> <br>of incorporation) (Commission<br><br> <br>File Number) (IRS. Employer<br><br> <br>Identification No.)

200Spectrum Center Drive, Suite 300

Irvine,CA 92618

(Addressof principal executive offices, including zip code)

(877)445-6047

(Registrant’stelephone number, including area code)

N/A

(Formername or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Written<br> communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting<br> material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement<br> communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement<br> communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act: None

Title<br> of each class Trading<br> Symbol(s) Name<br> of each exchange on which registered
Common FDCT OTCQB

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 1.01 Entry into a Material Definitive Agreement.

Effective at a date to be determined in May 2022, the Company will begin offering its securities under Rule 506(c) of Regulation D, as promulgated by the United States Securities and Exchange Commission. Rule 506(c) will permit the Company to broadly solicit and generally advertise this Offering, provided that all purchasers in the Offering are accredited, investors. The Company plans to take reasonable steps to verify purchasers’ accredited investor status and ensure that certain other conditions in Regulation D are satisfied.

The Company will offer for sale the following securities in a maximum combined amount up to $4,000,000.

Convertible Notes, the interest of 9% per annum, subject to optional and mandatory conversion into the Company’s common stock (the “Notes”). Subject to early conversion, each Note will mature twelve months from the execution date. The maximum amount of Notes to be sold is $3,000,000, subject to the Company’s option to accept additional subscriptions but not exceed $4,000,000.

All the Notes issued will automatically (and without any action on the part of the holders) be converted into shares of Common Stock of the Company at a conversion price (the “Conversion Price”) equal to 65% of the public offering price per share of the Common Stock offered to the public in the UPLIST or as such shares are valued in connection with another Mandatory Conversion Event. The UPLIST means means the listing of the Common Stock on a national securities exchange such as Nasdaq Capital Market with or without the capital raise or follow-on financing. The Company has engaged EF Hutton, a division of Benchmark Investments, LLC (“EF Hutton”), in connection with the proposed UPLIST and public offering.

If the UPLIST or other Mandatory Conversion Event does not occur by the Maturity Date, all the Notes will be either (i) paid in full by the Company or (ii) at the Company’s election, converted into shares of Common Stock with the shares of Common Stock valued at a pre-money valuation based on the closing bid price of shares of Common Stock outstanding as shown in the Company’s most recent Form 10Q or 10K filed with the SEC (the “Default Conversion Price”), however, in no event shall the Default Conversion Price be less than $0.07 per share of Common Stock with a maximum of 42,857,143 shares of Common Stock if the entire $3,000,000 in principal amount of Notes was converted.

This Offering will be made on a “best efforts” basis with no minimum.

The Company has entered into a “Lead Broker Engagement Agreement” with CIM Securities, LLC, (“CIM”) of Colorado. CIM will act as the placement agent in this Offering.

CIM is an independent investment bank that serves micro-cap and small-cap companies by providing capital raising solutions and also merger and acquisition services for companies seeking growth capital or services. CIM also caters to individual investors by providing comprehensive brokerage and money management solutions. CIM Securities provides institutional investors and individual investors periodic opportunities to participate in public offerings and private placements of public or private companies. The agreement (attached hereto) with CIM is summarized as follows:

1. Scope. CIM will act as the placement agent for up to $4,000,000 worth of the Company’s securities by soliciting accredited investors<br> and as the managing broker. The Company has engaged CIM to consult with and advise the Company with respect to the sale of these<br> Securities and anything incidental thereto, as directed by the Company.
2. Exclusivity Period. The sale of the Securities described in this Memorandum shall be handled exclusively by CIM. The exclusivity period shall<br> expire after the first three (3) months (“Term”) from the date of the Offering, or terminate upon ten days (10)<br> written notice by either party. After the exclusive term, the Agreement shall become non-exclusive and continue on a “month-to-month”<br> basis until either Party cancels.
--- ---
3. Fees and Compensation. The Company has agreed to pay CIM the following fee and other compensation: success fee, transaction success<br> fees, placement agent warrants, advisory fee, expense reimbursement, escrow account, and finder’s fees. CIM shall receive a<br> cash placement fee equal to Eight Percent (8.0%) of the gross proceeds and an extra Two Percent (2.0%) non-accountable expense allowance<br> & wholesaling fee that shall only be charged on monies & subscriptions that are brought in from any other FINRA member broker-dealer<br> other than CIM. Upon successful completion of an Equity, Mezzanine, and/or Structured Debt Transaction, the Company shall issue to<br> CIM, or its assignees, warrants for the purchase of an amount equal to Eight Percent (8.0%) of the number of total shares of stock<br> sold in the Offering contemplated herein this Agreement.

Additionally, Shares may be purchased or sold by officers, directors, employees, and affiliates of the Company, and persons will not receive any compensation based on the success of the Offering.

The following tables set forth the current equity capitalization of the Company, and the capitalization of the Company on a fully diluted basis, i.e., accounting for the Maximum 506c Offering at the mandatory conversion price, voting of preferred shares, conversion of all debt into equity, exercise of all warrants and options associated with the 506c Offering, and other outstanding common stock warrants after dilutive issuance adjustments.

Name and Addresses Title of Class Number of Shares Beneficially Owned Percent of Class, % Percent of Fully Diluted, %
Current Equity Structure, Common
Officers & Directors ^(1)^
Mitchell Eaglstein Common 20,768,105 14.03 % 10.46 %
Imran Firoz Common 14,310,000 9.67 % 7.21 %
Brian Platt Common 1,000,000 0.68 % 0.50 %
Jonathan Baumgart Common 600,000 0.41 % 0.30 %
Control Group/Affiliates ^(2)^
FRH Group Corporation Common 26,372,413 17.82 % 13.28 %
Thomas Family Trust Common 22,500,000 15.20 % 11.33 %
Public Holders/Investors ^(3)^ Common 62,475,032 42.21 % 31.46 %
Sub–Current Shares 148,025,550 100.00 % 74.54 %
Dilutive Events
AJB Capital Warrants ^(4)^ Common 4,285,714 2.16 %
New 506c Offering (Max Offering) ^(5)^
Common Shares Common 42,857,143 21.58 %
Underwriter Warrant Common 3,428,571 1.73 %
Subtotal Dilutive Events 50,571,429 25.46 %
Total 198,596,979 100.00 %
Name and Addresses Title of Class ^(6)^ Number of Shares Beneficially Owned Percent of Class, % Number of Voting Shares Percent of Fully Diluted Voting Shares, %
--- --- --- --- --- --- --- --- --- --- --- ---
Current Equity Structure, Preferred
Mitchell Eaglstein Series A Preferred 2,600,000 65.00 % 130,000,000 32.61 %
Imran Firoz Series A Preferred 400,000 10.00 % 20,000,000 5.02 %
Felix R. Hong Series A Preferred 1,000,000 25.00 % 50,000,000 12.54 %
Total 4,000,000 100.00 % 200,000,000 50.18 %

^(1)^Addresses for all officers and directors are 200 Spectrum Center Drive, Suite 300, Irvine, CA 92618.

^(2)^Shareholders having 10% or more of capital or voting rights in the Company as a control group.

^(3)^No single holder in this group owns 5% or more of common shares.

^(4)^The Company issued 1,000,000 warrants in connection with the $550,000 promissory note dated January 27, 2022, with an exercise price of $0.30 for three years and anti-dilution adjustments to the exercise price. Total number of common stock warrants after dilutive issuance = 1,000,000 (E) X $0.30 (F)/$0.07 (G) or 4,285,714. E = Total number of warrants, F = Exercise Price, G = Base Share Price or Mandatory Conversion Price.

^(5)^Entire 506c Offering is converted into equity at the mandatory conversion price of $0.07.

^(6)^Series A Preferred Stock is entitled to fifty (50) non-cumulative votes per share on all matters presented to stockholders for action. As a result, 4,000,000 Series A Preferred Shares represent a 50.59% voting percentage on a fully diluted vote per share basis. As a group of two persons, Officers and Directors own 75% of Series A Preferred stock.

CORPORATE

HISTORY

General

Under Delaware laws, the founders incorporated the Company on January 21, 2016, as Forex Development Corporation. On February 27, 2018, the Company changed its name to FDCTech, Inc. The name change reflects the Company’s commitment to expanding its products and services in the FX and cryptocurrency markets for OTC brokers. The Company provides innovative and cost-efficient financial technology (‘fintech’) and business solutions to OTC Online Brokerages and cryptocurrency businesses (“customers”).

The Company intends to build a diversified global financial services company driven by proprietary Condor trading technologies, complementary regulatory licenses, and a proven executive team. The Company plans to acquire, integrate, transform, and scale legacy financial service companies. The Company believes that its proprietary technology and software development capabilities allow legacy financial services companies immediate exposure to –forex, stocks, ETFs, commodities, crypto, social/copy trading, and other high-growth fintech markets.

From December 2021 onwards, the Company expects to grow from its acquisition strategy, specializing in buying and integrating small to mid-size legacy financial services companies. The Company intends to build a diversified global software-driven financial services company. The Company plans to acquire, integrate, transform, and scale legacy financial service companies. The Company replaces conventional legacy software infrastructure with its regulatory-grade proprietary Condor trading technologies, intending to improve end-user experience, increase client retention, and realize cost synergies.

On December 22, 2021, the Company entered into a Share Exchange Agreement (the “Agreement”) with AD Financial Services Pty Ltd ACN 628 331 117 of Level 38/71 Eagle St, Brisbane, Queensland, Australia, 4000 (“ADFP” or “Target”). According to the Agreement, the Company acquired 51% of ADFP’s issued and outstanding shares of capital stock in exchange for 45,000,000 (the “Consideration”) newly issued “restricted” common shares. The operating and licensed entity of ADFP is AD Advisory Services Pty Ltd. ADFP owns one hundred percent (100%) equity interest in AD Advisory Services Pty Ltd (“ADS”). As a result, the Company is 51% owner of ADS. The Company closed the acquisition on December 22, 2021, and combined the financial statements of ADS in its annual report, 10-K, filed with the SEC on March 28, 2022.

Post-acquisition of ADS, we have two primary business segments, (1) Wealth Management and (2) Technology and Software Development.


WealthManagement

AD Advisory Services Pty Ltd. (ADS) is an Australian-regulated wealth management company with 20 offices, 28 advisors, and $530+ million in funds under advice. ADS provides licensing solutions for financial advisers & accountants in Australia. ADS offers different licensing, compliance, and education solutions to financial planners to meet the specific needs of their practice.

Technology& Software Development

The Company secures and earns revenues by signing an agreement with its customers. The Company considers a signed agreement with its customers, a binding contract with the customer, or other similar documentation reflecting the terms and conditions under which the Company will provide products or services as persuasive evidence of an arrangement. Each agreement is specific to the customer and clearly defines each party’s fee schedule, duties and responsibilities, renewal and termination terms, confidentiality agreement, dispute resolution, and other clauses necessary for such a contract. The material terms of contracts with customers depend on the nature of services and solutions. Each contract is specific to the customer and clearly defines each party’s fee schedule, duties and responsibilities, renewal and termination terms, confidentiality agreement, dispute resolution, and other clauses necessary for such contract.

The Company has three sources of revenue.

Consulting Services – The Company’s turnkey business solutions - Start-Your-Own-Brokerage (“SYOB”), Start-Your-Own-Prime<br> Brokerage (“SYOPB”), Start-Your-Own-Crypto Exchange (“SYOC”), FX/OTC liquidity solutions, and lead generations.
Technology Solutions – The Company licenses its proprietary and, in some cases, acts as a reseller of third-party technologies to<br> customers. Our proprietary technology includes but is not limited to Condor Risk Management Back Office (“Condor Risk Management”),<br> Condor Pro Multi-Asset Trading Platform (previously known as Condor FX Pro Trading Terminal), Condor Pricing Engine, Crypto Web Trader<br> Platform, and other cryptocurrency-related solutions.
Customized Software Development – The Company develops software for Customers with unique requirements outlined in the Software Development<br> Agreement (“Agreement”).

The Company has completed the Condor Pro Multi-Asset Trading Platform, previously known as Condor FX Trading Platform. The Condor Pro Multi-Asset Trading Platform is a commercial trading platform targeted at day traders and retail investors. The industry characterized such platforms by their ease of use and various helpful features, such as the simplified front-end (user interface/user experience), back-end (reporting system), news feeds, and charting system. The Condor Pro Multi-Asset Trading Platform further includes risk management (dealing desk, alert system, margin calls, etc.), pricing engine (best bid/ask), and connectivity to multiple liquidity providers or market makers. We have tailored the Condor Pro Multi-Asset Trading Platform to different markets, such as forex, stocks, commodities, cryptocurrencies, and other financial products.

The Company released, marketed, and distributed its Condor Pro Multi-Asset Trading Platform in the second quarter of the fiscal year, December 31, 2019. The Company has developed the Condor Back Office API to integrate third-party CRM and banking systems into Condor Back Office.

The Company currently has six (6) licensing agreements for its Condor Pro Multi-Asset Trading Platform. The Company is continuously negotiating additional licensing agreements with several retail online brokers to use the Condor Pro Multi-Asset Trading Platform. Condor Pro Multi-Asset Trading Platform is available as a desktop, web, and mobile version.

The Company’s upgraded Condor Back Office (Risk Management) meets various jurisdictions’ regulatory requirements. Condor Back Office meets the directives under the Markets in Financial Instruments Directive (MiFID II/MiFIR), legislation by European Securities and Market Authority (ESMA) implemented across the European Union on January 3, 2018.

The Company is developing the Condor Investing & Trading App, a simplified trading platform for traders with varied experiences in trading stocks, ETFs, and other financial markets from their mobile phones. The Company expects to commercialize the Condor Investing & Trading App by the end of the second quarter of the fiscal year ended December 31, 2022.

The Company is developing NFT Marketplace, a decentralized NFT marketplace, a multichain platform with a lazy minting option to reduce and limit unnecessary blockchain usage fees, also known as gas fees. The Company expects to commercialize the NFT Marketplace by the end of the second quarter of the fiscal year ended December 31, 2022.

The Company and its subsidiary, ADS, are developing a digital wealth management company, which will initially include a Robo Advice Platform catering to Australia’s wealth management industry. The Company expects to commercialize the Robo Advice Platform by the fiscal year ended December 31, 2022.

Additional information can be obtained from the Company’s SEC filings.

Information in this report on Form 8-K shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise incorporated by reference into any filing pursuant to the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise expressly stated in such filing.

ITEM 9.01 F****inancial Statements and Exhibits

(d) Exhibits.

Exhibit<br> Number Description
99.1 Lead Broker Engagement Agreement with CIM Securities LLC.
104 Cover<br> Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

FDCTECH,<br> INC.
May<br> 27, 2022 By: /s/ Imran Firoz
Date Imran<br> Firoz
Chief<br> Financial Officer
(Principal<br> Executive Officer)

Exhibit99.1

CIMSecurities, LLC

Member FINRA / SIPC

CIMTree2

A Choice for ALL Seasons

April 19, 2022

Via Email: imran@fdctech.com

PERSONAL& CONFIDENTIAL

Mr. Imran Firoz

Co-Founder & CFO

FDCTech, Inc.

200 Spectrum Center Drive, Suite 300

Irvine, CA 92618

Dear Mr. Firoz,

This letter ((together with Exhibit A and Exhibit B) annexed hereto and made a part hereof), all of which taken together constitute this entire Engagement Agreement (“Agreement”) and confirms our complete understanding with respect to the retention of CIM Securities, LLC (“CIM”) as the non-exclusive Investment Banker and Lead Placement Agent to FDC Tech, Inc. (the “Company”) a company formed under the laws of in the State of Delaware as a C Corporation with its principal offices located at the address listed above in connection with the Best Efforts REGD 506c general solicitation equity offering (final terms and structure to be mutually agreed upon) of up to $3 million gross proceeds structured as either an 8% Convertible Note with Warrants to be equally priced at a discount of 35% to the pending Uplisting with EF Hutton or an 8% PIK Dividend Series A Convertible Participating Preferred equity financing (“Transaction” and/or “Financing”). The Pre-Money Valuation for the Company on a fully diluted basis, including all convertible securities, options, warrants, and employee stock pools, will be no more than $30 million. The parties agree that there may be multiple closings for the Transaction and that there is no minimum amount for any closing. The Agreement shall be for a three (3) months (“Term”) from the date of this fully executed Agreement on a non-exclusive basis; this Engagement Agreement shall continue to be non-exclusive and continue on a “month-to-month” basis until either Party cancels this Engagement Agreement in writing giving ten days written notice to either Party.

It is understood that at least one primary objective of this Engagement Agreement is a private capital raise with Accredited Investors, whether it is to obtain equity financing and/or debt financing, and it is on a “best efforts” basis. CIM makes no representation or promise as to whether its efforts shall be successful and can be no assurance that any funds will actually be raised. Consequently, the Company should not make any reliance whatsoever that this “best efforts” capital raise shall actually succeed.

Upon the terms and subject to the conditions set forth hereinafter, the parties hereto agree as follows:

1. Appointment.<br> The Company hereby retains CIM through certain individuals who are registered and licensed with FINRA as investment bankers (the<br> “Representatives”) associated and supervised by CIM. CIM and the Representatives hereby agree to act as the Company’s<br> Exclusive Placement Agent and Investment Banker in connection with any possible Transaction and the financial advisory services as<br> more specifically set forth in paragraph 2 below, effective as of the date hereof (the “Effective Date”). Nothing in<br> this Engagement Agreement shall be construed so as to (i) obligate the Company to complete the Transaction or any Transaction or<br> any other transaction or (ii) entitle CIM to any fees or other compensation with respect to potential investors with whom the Company<br> declines, in its sole and absolute discretion, to pursue the Transaction.
2. Scope<br> and Certain Conditions of Services. The Company hereby engages CIM and the Representatives to consult with and advise the Company<br> with respect to the Transaction and anything incidental thereto, as directed by the Company. The Company expressly acknowledges and<br> agrees that the obligations of CIM and the Representatives hereunder with respect to the Transaction are on a reasonable “best<br> efforts” basis only and that the execution of this Engagement Agreement does not constitute a commitment by CIM and the Representatives<br> to provide financing to the Company and does not ensure the success of securing any financing on behalf of the Company. CIM and the<br> Representatives’ services shall include, if appropriate or if reasonably requested by the Company: (a) reviewing the Company’s<br> financial condition, operations, competitive environment, prospects, market viability, and related matters for potential investors;<br> (b) reviewing and suggested editing the related due diligence information package / Data Room and review confidential memorandum<br> and/or private placement memorandum (CIM does not draft any Offering Memorandums that is the Company’s responsibility with<br> its legal counsel (c) soliciting, coordinating conference calls / setting up meetings, and evaluating indications of interest and<br> proposals regarding a Transaction; (d) advising the Company as to the structure of a Transaction; (e) helping introduce the Company<br> to other retail & institutional investors via an investor relations firm and direct investment banking & corporate finance<br> bankers after the Capital Raise portion of this Agreement and (f) providing other financial advisory and investment banking services<br> reasonably necessary to accomplish the foregoing.
--- ---
Please<br> be advised that any material prepared or reviewed by CIM and/or any terms of any proposed transaction and/or any portion of this<br> material that is used to secure a transaction shall be considered brought to the Company by and/or from CIM.
3. CIM<br> Securities, LLC. The Representatives are registered and supervised by CIM Securities, LLC, a registered broker/dealer and member<br> of FINRA/SIPC. All securities contemplated herein shall be offered through CIM. Required supervision by CIM of registered investment<br> bankers includes, among other things, approval of executed Engagement Agreements and due diligence oversight. In the event the registered<br> banker resigns from CIM, the Agreement is still in full force and effect with CIM and can only be assigned to another registered<br> broker-dealer upon the approval of CIM executive management.
4. Fees<br> and Compensation. In consideration of the services rendered hereunder, the Company agrees to pay CIM the following fee and other<br> compensation:
a. Success Fee*.* Upon each successful closing of the Transaction, CIM shall be entitled to the following:
--- ---

Equity/ Mezzanine / Structured Debt Transaction - If the Company consummates an Equity Financing (to include debt that is convertible into equity and/or includes warrants, mezzanine financing, unitranche and/or structured debt finance), defined as a corporate investment or financial investment of/with/into the Company, or if stock/equity is purchased directly from a shareholder(s) of the Company, in the course of one or more rounds of investments including, without limitation, a minority or majority investment of either equity securities, research and development funding or non-recurring funding, CIM shall receive a cash placement fee equal to Eight Percent (8.0%) of the gross proceeds and an extra Two Percent (2.0%) non-accountable expense allowance & wholesaling fee that shall only be charged on monies & subscriptions that are brought in from any other FINRA member broker-dealer other than CIM. CIM may “re-allow” any portion it negotiates with other FINRA licensed brokers as well, but cash commissions shall not be more than Ten Percent (10.0%). Should the Company bring in any Investors of its own, then it will pay CIM only Four Percent (4.0%) on all monies received by the Company from its Investors that participate in the Offering.

SeniorDebt Transaction – If the Company consummates only a Senior Debt Transaction (defined as a secured debt loan NOT convertible into common or preferred stock), then the Company will pay CIM a Three (3%) Percent Cash Fee-only and Zero (0%) Warrants as outlined in Section 4(b) below.


M&ATransaction - The Company agrees to pay an M&A fee equal to Five Percent (5%) of total aggregate consideration (“Aggregate Consideration”) paid for any transaction completed between the Company and any targeted buyout, acquisition and/or merger (the “Target”) introduced, directly or indirectly, by CIM and/or its introduced affiliates. For purposes of this Agreement, the “Aggregate Consideration” shall mean the total value received by the Company or paid for a Target in any transaction(s) and shall include (i) the aggregate value of all cash, securities, the assumption (or forgiveness) of debt and minority interest obligations, and any other forms of payment received or to be received, directly or indirectly, or paid, by the Company/Target (or any of its subsidiaries), its stockholders, or a third party, as the case may be; (ii) amounts received under the terms of any “seller note financing” and/or “earn-out” provision, rights to receive periodic payments and all other rights that may be at any time transferred or contributed to, or by, the Company/Target (or any of its subsidiaries), its affiliates or shareholders in connection with an acquisition of or by the Company/Target or of the assets thereof; and (iii) amounts receivable or payable under consulting agreements in lieu of purchase price, above-market employment contracts to the extent above market, all non-compete agreements or similar arrangements, and all contingent payments in connection with any transaction. CIM shall be paid a full fee based on the entire Aggregate Consideration at the time of closing the Target Transaction, payable in cash. Any stock or equity compensation paid to CIM would need to be mutually agreed upon in writing before the Target Transaction closes by a superseding new agreement covering this Section 4(a)(ii).

BusinessDevelopment Transaction - The Company shall pay a business development fee equal to Five Percent (5%) of the total gross value to the Company of any and all contracts and/or other business development deals with any party worked or introduced, directly or indirectly, by CIM and/or its introduced affiliates. All such fees due hereunder shall be payable as the Company is paid on any and all such contracts, and which fees shall be payable through to the completion or Termination of the contract(s), inclusive of any and all change orders, amendments, and extensions, irrespective of the Term and termination provisions of this Agreement. The Transaction Success Fee is due and payable immediately upon the closing of the Transaction and shall be dispersed directly to CIM simultaneously with the delivery of the proceeds of the Transaction to the Company.

The Transaction Success Fees mentioned in Section 4(a) are due and payable immediately upon the closing of the Transaction or within three business days after each consecutive or rolling Closings and shall be disbursed directly to CIM with the delivery of the proceeds of the Transaction to the Company.

b*.* Placement Agent Warrants. In addition to compensation described in Section 4(a.), CIM shall also be entitled to the issuance of<br> seven (7) year term cashless exercisable placement agent warrants (“Placement Agent Warrants” or “Warrants”)<br> as described herein. Upon successful completion of an Equity, Mezzanine, and/or Structured Debt Transaction, the Company shall issue<br> to CIM, or its assignees, warrants for the purchase of an amount equal to Eight Percent (8.0%) of the number of total shares of stock<br> sold in the Offering contemplated herein this Agreement. If the Company brings in any Investors of its own then it will pay CIM only<br> Four Percent (4.0%) in Warrants for those amounts sourced by the Company. The Placement Agent Warrants shall be substantially in<br> the form attached hereto as Exhibit B and be exercisable into common stock as well as shall be dated for 7 years after the Transaction<br> closes, non-callable, non-cancelable, assignable Warrants with immediate piggy-back registration rights and cashless exercise provisions.<br> The warrants shall also have customary anti-dilution provisions for stock dividends, splits, mergers, stock issuances etc. at a price(s)<br> below said exercise price per share and shall provide for automatic exercise immediately prior to expiration. (Exhibit B). Such Warrants<br> would not be payable until a Transaction is consummated and Warrants shall be paid for by a minimal $100 cost for said Warrants but<br> then shall be subsequently exercisable at the same price the investors receive in the Transaction whether that is an Equity, Mezzanine<br> Debt with Warrants Deal, Structured Debt and/or Senior Debt.
c. Advisory Fee. A non-contestable and non-refundable upfront retainer For Advisory Services rendered, the Company shall pay CIM<br> a Fifteen Thousand Dollar ($15,000) cash advisory and due diligence fee, payable by the Company to CIM via a wire after signing this<br> Agreement. Then the Company has agreed to pay a remaining $10,000 in retainer to CIM at the earlier of 45 days from the date of this<br> Agreement or when the Company has secured at least $250,000 from Investors after the date of this Agreement whichever comes first.<br> Nonpayment of this fee within Three (3) business days may render this Agreement null and void.
--- ---
d*.* Expense Reimbursement. The Company agrees to reimburse CIM for all of its out-of-pocket expenses incurred by the Representative(s)<br> or CIM; however, any expense in excess of $100 shall be pre-approved in writing or Email by the Company. Such expenses may include<br> attendance at investor shows or conferences, and other expenses that may arise. The Company is expressly expected to reimburse CIM<br> Securities for its background checks on all Officers, Directors and 20% Beneficial Holders which shall not exceed $500 per background<br> check. Placement Agents counsel fees, which shall not exceed $5,000 in total, to review final PPM and provide Legal Services as it<br> would pertain to legal review and due diligence questions that arise in the PPM, Due Diligence Data Room and / or Preliminary Information<br> Materials which shall be approved by the Company and CIM prior to distribution to investors. Any such costs shall be in writing before<br> hiring Placement Agents Legal Counsel and CIM shall share the fee agreement between our firm and our Legal Counsel.
e. Escrow Account. CIM would mandate usage of an FDIC Insured Bank Escrow Account for any Contingent REG D Offering or it may allow<br> the Company to receive money without an Escrow on an ongoing basis under a “Non-Contingent Offering”. A) If a Contingent<br> Offering is conducted then all amounts payable (not to include the non-refundable retainer) hereunder shall be paid to CIM out of<br> a Three Party Escrow account paid for by the Company and located here in the United States of America at a FDIC Insured Banking Institution<br> that is acceptable to CIM at the closing or by such other means acceptable to CIM during the time of any Offering. B) The Company<br> and CIM may choose during the course of this Agreement and Term to do a best efforts with a “no minimum offering” Non-Contingent<br> Offering at which time there would be no Escrow Account required. HOWEVER, in such case, the Company must receive written approval<br> by CIM’s Chief Compliance Officer before accepting any investor funds from any investor prior to sending out the Company’s<br> wire instructions, receiving a wire, cashing an investor’s check made out to the Company, ACH or any other method of payment.<br> Thereafter the Company shall be obligated to make payment of the Broker Commissions or Advisory Fees to CIM within five (5) business<br> days of receiving funds from said Transaction. Failure to notify CIM of an investor is terms for cancellation of this Agreement.
f. Finder’s Fees. The Company is not obligated to pay, and there are no outstanding claims for, any type finder’s fees or other<br> introducing non-registered broker fees in connection with the Offering or Transaction of securities that CIM shall be assisting the<br> Company during the Term of this Agreement. The Company warrants and attests that no unregistered “finders” or “brokers”<br> shall be paid any success fee based compensation with respect to any Transaction CIM is paid on if successful at such Transaction.
5. Payment<br> Instructions. All success fees, expense reimbursements, retainer and other payments made by the Company pursuant to this Engagement<br> Agreement shall be made directly to CIM. All payments shall be made by wire and wiring instructions are below.
--- ---
Wire<br> Instructions to CIM are as follows:
--- --- ---
ABA/Routing<br> Number: 107<br> 005 953
Bank<br> Name: Citywide<br> Banks
Address: 10660<br> E. Colfax Ave
Aurora,<br> CO 80010
Account<br> Number: 1868522
Beneficiary<br> Name: CIM<br> Securities, LLC
Beneficiary<br> Address: 6898<br> S. University Blvd, Suite 270
Centennial,<br> CO 80122
Attn:<br> James Holt, President

CIM, pursuant to separate agreements, may retain or allocate any or all of the compensations or other amounts payable under this Engagement Agreement among the Representatives or their assigns. This Engagement Agreement shall not be terminated by virtue of any change in employment of the Representatives or Termination of the Representatives’ supervision by CIM; and in such event, CIM shall remain entitled to receive the compensation hereunder and may adjust allocations among the Representatives and others to account for relative efforts and success in regard to a Transaction.

6. Term<br> of Retention. This Engagement Agreement’s exclusivity period shall expire Three (3) months from the date of its execution<br> or terminate upon ten days (10) written notice by either Party (“Termination”). Notwithstanding the foregoing, no expiration<br> or Termination of this Engagement Agreement shall affect: (a) CIM’s right to receive, and the Company’s obligation to<br> pay, any Transaction Success Fee (as set forth in paragraphs 4 and 5); (b) the choice of law and forum, and (c) the indemnification<br> provisions set forth in Exhibit A. If within twelve (12) months following the Termination of this Engagement Agreement, the Company<br> enters into an agreement to accept any type of capital from any prospective target/partner introduced to the Company by or through<br> CIM or the Representatives prior to or during the Term of this Engagement Agreement, the Company’s obligations to pay fees<br> and compensation, as defined in paragraphs 4 and 5, are triggered. At the end of the initial exclusive Term, this Engagement Agreement<br> shall continue on a month-to-month basis until Ten days (10) written notice of Termination by either Party.
7. Non-Circumvention.<br> The CIM introduction of investors and/or other counter-parties in any Transaction, and the potential investors or other counter-parties<br> who are introduced to the Company by the Representatives or CIM before or during the Term of this engagement Agreement, and all of<br> their respective affiliates currently existing or formed hereafter (collectively “Purchasers” or “Covered Persons”),<br> shall be considered, for purposes of this engagement Agreement, the property of CIM. The Company on behalf of itself, its parent<br> company and/or any of its subsidiaries agree not to circumvent, directly or indirectly, CIM’s relationship with these purchasers,<br> investors or Covered Persons, their parent companies and / or any of the Purchasers’ subsidiaries or Affiliates and Company<br> shall not directly or indirectly contact or negotiate with any of the Covered Persons regarding a Transaction with the Company, or<br> with any other company, and shall not enter into any agreement or Transaction with Covered Persons, or disclose the names of Covered<br> Persons, except as such disclosure may be required by any law, rule, regulation, regulatory body, court or administrative agency,<br> during the applicable Non-Circumvention Period (24 months) without the prior written approval of CIM, and the Representatives. In<br> the event that the Company enters into a Transaction or a “Subsequent Transaction” from a Covered Person in any placement<br> during the applicable Non-Circumvention Period (regardless of whether such placement is arranged without an agent or through an agent<br> other than CIM), the Company agrees to pay to CIM a fee equal to as disclosed herein of sales commissions, warrants, and / or aggregate<br> consideration received by the Company provided under this engagement Agreement.
8. Due<br> Diligence. The Company agrees to furnish the Representatives and CIM with such information regarding the business and financial<br> condition of the Company as is reasonably requested, all of which shall be, to the Company’s best knowledge, after due inquiry,<br> accurate and complete at the time furnished. The Company shall promptly notify the Representatives and CIM if it learns of any material<br> misstatement in, or material omission from, any information previously delivered to the Representatives or CIM. The Representatives<br> and CIM shall conduct independent due diligence on the Company and may terminate this engagement Agreement should its due diligence<br> findings not be reasonably consistent with the representations (oral and written) made by the Company. The Company will also be required<br> to keep a VPN Data Room open and available to the Principals and Registered Reps and Investment Bankers of CIM during the full Term<br> of this Agreement and for 30 days following any Termination in writing by either Party.
9. Public<br> Announcements. Prior to any press release or other public disclosure relating to any and all investment banking or advisory services<br> hereunder in this Agreement which is legally permissible, the Company, and CIM shall confer and reach Agreement upon the contents<br> and method of any such disclosure and get it in writing. No Press Release or General Statement may be made to the Public about any<br> such Offering unless mutually agreed to in writing by both Parties.
10. Confidentiality.<br> The Representatives and CIM shall keep all information obtained from the Company strictly confidential except: (a) for information<br> which is otherwise publicly available, or previously known to the Representatives or CIM or was obtained by the Representative(s)<br> or CIM independently of the Company and without breach, of the respective Representative(s) or CIM’s agreements with the Company;<br> (b) the Representatives or CIM may disclose such information to their affiliates, shareholders, officers, directors, representatives,<br> agents, employees, regulatory administrators and attorneys, and to financial institutions, but shall ensure, to the best of their<br> ability, that all such persons shall keep such information strictly confidential; (c) pursuant to any order of a court of competent<br> jurisdiction or other governmental or quasi-governmental body (the Representatives or CIM, as the case may be, shall give written<br> notice to the Company of such order within forty-eight (48) hours of receipt of such order); and (d) upon prior written consent of<br> the Company. The Company agrees that any report or opinion, oral or written, delivered to it by the Representatives or CIM is prepared<br> solely for its confidential use and shall not be reproduced, summarized, or referred to in any public document or given or otherwise<br> divulged to any other person, other than its employees, attorneys and prospective investors that the Representatives or CIM have<br> introduced to the Company, without the prior written consent of CIM and if the same was prepared and delivered by CIM the prior written<br> consent of CIM, except disclosure by the Company as may be required by applicable law or regulation, in which event CIM’s Registered<br> Representative consent shall not be unreasonably withheld or delayed.
--- ---
11. Compliance<br> with Securities Laws. The Company and CIM agree to conduct the Transaction in a manner intended (a) to qualify as a private placement<br> of the Company’s securities (the “Securities”) in any jurisdiction in which the Securities are offered (including<br> the U.S.), (b) if the Financing Transaction is made to non-U.S. investors outside the U.S., to comply with the requirements of Regulation<br> S under the Securities Act of 1933, as amended (the “Securities Act”), and (c) if the Financing Transaction is made in<br> the U.S. or to U.S. investors, to comply with the requirements of Rule 506(c) of Regulation D promulgated under the Securities Act.<br> Assuming the accuracy of the representations and warranties given to the Company by each investor to the extent relevant for such<br> determination, the Transaction shall be exempt from the registration requirements of the Securities Act. In connection with offers<br> made pursuant to Regulation S, the Company agrees not to engage in any “directed selling efforts” (as that Term is defined<br> in Regulation S) with respect to the Securities and to comply with the offering restriction requirements of Regulation S. In connection<br> with offers made in the U.S. pursuant to Regulation D, the Company agrees to limit the PPM and subscription offers to sell, and solicitations<br> of offers to buy, the Securities to persons reasonably believed by it to be “accredited investors” within the meaning<br> of Rule 501(a) under the Securities Act, and If the Securities are offered in the U.S., the Company agrees to conduct the Financing<br> Transaction in a manner intended to comply with the registration or qualification requirements, or available exemptions therefrom,<br> under applicable state securities laws. The Company shall be responsible for compliance with the filing requirements of the securities<br> laws of all applicable countries, states of the U.S., and other jurisdictions. CIM shall advise the Company of those states of the<br> U.S. and other jurisdictions in which CIM intends to offer the Securities in order that the Company’s counsel can ensure that<br> the Transaction has been qualified or exempted under the appropriate laws and regulations. CIM shall not engage in sales of the Securities<br> in any state requiring pre-sale qualification until the Company has qualified to sell Securities in such State. The Company has not<br> in the six months prior to the date of this Agreement and shall not, for a period of six months following the final closing date<br> of the Financing Transaction, directly or indirectly, make any offers or sales of any security or solicit any offer to buy any security<br> unless such offer or sale does not (y) jeopardize the availability of exemptions from the registration and qualification requirements<br> under applicable U.S. federal securities laws, state securities laws, or the securities laws of any other jurisdiction with respect<br> to the Financing Transaction and (z) cause the Financing Transaction to be integrated with such other Offering for purpose<br> of any stockholder approval provisions applicable to the Company or its securities.
12. Company<br> Representations and Warranties. The Company represents and warrants to CIM that: (a) it is duly incorporated and is validly existing<br> and in good standing under the laws of the State of for which listed on the first page in this Agreement, (b) it has full power and<br> authority to enter into and perform its obligations under this Engagement Agreement, and (c) this Agreement has been duly and validly<br> authorized by the Company, and, when executed and delivered, shall constitute, the valid and binding Agreement of the Company, enforceable<br> against the Company in accordance with its terms, except: (i) as such enforceability may be limited by bankruptcy, insolvency, reorganization<br> or similar laws affecting creditors’ rights generally, (ii) as enforceability of any indemnification or contribution provision<br> may be limited under the federal and State securities laws, and (iii) that the remedy of specific performance and injunctive and<br> other forms of equitable relief may be subject to the equitable defenses and to the discretion of the court before which any proceeding<br> therefore may be brought (collectively, the “Enforceability Limitations”).
13. CIM<br> Representations and Warranties and Covenants. CIM represents and warrants to the Company that: (a) it is a member in good standing<br> of the Financial Industry Regulatory Authority, Inc., (b) it is registered as a broker/dealer under the Securities Exchange Act of<br> 1934, as amended, (c) it is licensed as a broker/dealer under the laws of the states applicable to the offers and sales of the securities<br> by CIM, (d) it is duly organized and is validly existing and in good standing under the laws of the State mentioned on the first<br> page of this Agreement (e) it has full power and authority to enter into and perform its obligations under this Agreement, (f) this<br> Agreement has been duly and validly authorized by CIM, and, when executed and delivered, shall constitute, the valid and binding<br> Agreement of CIM, enforceable against CIM in accordance with its terms, except as may be limited by the Enforceability Limitations,<br> and (g) neither it nor any person associated with it who is or shall be paid (directly or indirectly) remuneration for solicitation<br> of purchasers in connection with a Financing Transaction, nor any director, executive officer or other officer of it participating<br> in a Financing Transaction (each, a “CIM Covered Person”) is subject to any is subject to any of the “Bad Actor”<br> disqualifications described in Rule 506(d)(1)(i) to (viii) under the Securities Act of 1933, as amended (a “Disqualification<br> Event”). CIM has exercised reasonable care to determine whether any CIM Covered Person is subject to a Disqualification Event.<br> CIM covenants that it (i) shall use its reasonable best efforts to conduct a Financing Transaction in compliance with the provisions<br> of this Agreement and the requirements of applicable law, and (ii) shall not engage in any form of broad solicitation or advertising<br> in performing its duties under this Agreement including, without limitation, any mass mailing (or emails), general solicitation or<br> advertising.
--- ---
14. Other<br> Engagements. The Company acknowledges that CIM, the Representative(s) and their respective affiliates may have, and may continue<br> to have, investment banking or other relationships with persons and entities other than the Company, about or from which the Representative(s)<br> and CIM may acquire information of interest to the Company. The Representative(s) and CIM shall have no obligation to disclose such<br> information to the Company or to use such information in connection with this Engagement Agreement.
15. Indemnification.<br> The Company agrees to provide indemnification, contribution, and reimbursement to CIM and certain other persons in accordance with,<br> and further agrees to be bound by, the provisions set forth in Exhibit A attached to, incorporated in, and made an integral part<br> of, this Engagement Agreement by this reference.
16. Specific<br> Performance. The Company acknowledges and agrees that, if it breaches its obligations under this Engagement Agreement to issue<br> warrants, damages at law shall be an insufficient remedy to CIM and that CIM would suffer irreparable damage as a result of such<br> violation. Accordingly, it is agreed that CIM shall be entitled, upon application to a court of competent jurisdiction, to obtain<br> injunctive relief against the breaching Party to enforce the provisions of such sections, which injunctive relief shall be in addition<br> to any other rights or remedies available to CIM.
17. Authority.<br> By signing this Engagement Agreement, each signing Party represents that its representative or representatives signing this Engagement<br> Agreement have unconditional authority to enter into this Engagement Agreement on behalf of the Party.
18. Company’s<br> Business Model. The Company agrees to not substantially change their business model after signing this Agreement. Substantially<br> changing the business model may result in CIM terminating this Agreement and engagement/retainer fees shall not be returned. If a<br> change must be made, CIM has the right to approve the change and move forward as the Investment Banker with a revised engagement<br> agreement or terminate this Agreement with no refund of fees paid by the Company.
19. Entire<br> Agreement. Any amendment to this Engagement Agreement must be in writing signed by duly authorized representatives of the parties<br> hereto and stating the intent of the parties to amend this Engagement Agreement. This Engagement Agreement contains the entire understanding<br> between the parties relating to the subject matter of this Engagement Agreement. All prior or contemporaneous agreements, understandings,<br> representations and statements, whether direct or indirect, oral or written, are merged into and superseded by this Engagement Agreement<br> and shall be of no further force or effect. This Engagement Agreement shall be binding upon, and shall inure to the benefit of, the<br> parties and their respective successors and assigns. This is a fully integrated Engagement Agreement. Each Party represents, warrants,<br> agrees and admits that it has not entered into this Engagement Agreement in reliance upon any promise or representation not expressly<br> set forth in this Engagement Agreement.
--- ---
20. Severability.<br> The invalidity or unenforceability of any provision of this Engagement Agreement shall not affect the validity or enforceability<br> of any other provision of this Engagement Agreement, which shall remain in full force and effect in accordance with the terms hereof.<br> The Company agrees that it shall be solely responsible for ensuring that the Transaction or any transaction complies with applicable<br> law.
21. Attorneys’<br> Fees. In any litigation, arbitration, or other proceeding by which one Party either seeks to enforce its rights under this Engagement<br> Agreement or seeks a declaration of any rights or obligations under this Engagement Agreement, the prevailing Party shall be awarded<br> reasonable attorneys’ fees, together with any costs and expenses, including expert witness fees, to resolve the dispute and<br> to enforce the final judgment.
22. Arbitration.<br> All claims and disputes arising under or relating to this Engagement Agreement are to be settled by binding arbitration in the State<br> of Colorado or in the federal court sitting in the Arapahoe County district of Colorado, or another location mutually agreeable to<br> the parties subsequent to either Party making a claim to adjudicate. The arbitration shall be conducted on a confidential basis pursuant<br> to the Commercial Arbitration Rules of the American Arbitration Association. Any decision or award as a result of any such arbitration<br> proceeding shall be in writing and shall provide an explanation for all conclusions of law and fact and shall include the assessment<br> of costs, expenses, and reasonable attorneys’ fees. Any such arbitration shall be conducted by an arbitrator experienced in<br> the securities industry and shall include a written record of the arbitration hearing. The parties reserve the right to object to<br> any individual who shall be employed by or affiliated with a competing organization or entity. An award of arbitration may be confirmed<br> in a court of competent jurisdiction.
23. Notices.<br> Unless otherwise provided by statute or by Agreement of the parties, all notices herein shall be in writing and shall be delivered<br> to the other Party by registered or certified mail or personally delivered. Such notice shall be deemed received on the date the<br> notice is actually received or Five (5) days after the date is mailed by registered or certified mail, whichever occurs first.
24. Jurisdiction.<br> Each Party hereby irrevocably (a) agrees that any suit or other legal proceeding arising out of or relating to this Engagement Agreement<br> may be brought only in a court of the State of Colorado or in the federal court sitting in Arapahoe County, Colorado, (b) consents,<br> for itself and in respect of its property, to the jurisdiction of each such court in any such suit or proceeding, and (c) waives<br> any objection that it may have to the laying of the venue of any such suit or proceeding in any of such courts and any claim that<br> any such suit or proceeding has been brought in an inconvenient forum. This Engagement Agreement shall be governed by the laws of<br> the State of Colorado without regard to such State’s rules concerning conflicts of laws.

Please confirm that the foregoing terms are in accordance with your understanding by signing and returning the enclosed duplicate original of this Engagement Agreement.

This Engagement Agreement Offer shall expire if not signed by Company by five business days from the date on page 1 hereto at 5:00 pm Pacific Standard Time and shall then be considered null and void.

ACCEPTED<br> AND AGREED TO:
Company: FDCTech,<br> Inc.
Signature: /s/<br> Imran Firoz
Name: Imran<br> Firoz
Title: CFO,<br> Director
Date: 04/18/22
Email: imran@fdctech.com
CIM<br> Securities, LLC On<br> behalf of the CIM Representative
--- --- --- ---
Signature: /s/<br> James Holt Signature: /s/<br> John G. Myers
Name: James<br> Holt Name: John<br> G. “Jack” Myers
Title: President Title: Registered<br> Representative
Date: April<br> 19, 2022 Date: April<br> 19, 2022

EXHIBITA

INDEMNIFICATION

The Company (the “Indemnifying Party”) agrees to indemnify and hold harmless the Representatives, CIM, its respective affiliates and each of their respective officers, directors, employees, agents and controlling persons within the meaning of Section 15 of the Securities Act of 1933, as amended (the “Act”) or Section 20(a) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) (each, an “Indemnified Party”), against any and all loss, charge, claim, damage, expense and liability whatsoever, including, but not limited to, all attorneys’ fees and expenses (hereinafter a “Claim” or “Claims”), related to or arising in any manner out of, based upon, in connection with or contemplated by this Engagement Agreement. No Indemnified Party shall be liable in respect of any Claims that a court of competent jurisdiction has judicially determined by final judgment (and the time to appeal has expired or the last right of appeal has been denied) resulted from the gross negligence or willful misconduct of an Indemnified Party. Each Party further agrees that it shall not, without the prior written consent of each Indemnified Party, settle, compromise or consent to the entry of any judgment in any pending or threatened proceeding in respect of which indemnification may be sought hereunder (whether or not any Indemnified Party is an actual or potential party), unless such settlement, compromise or consent (i) includes an unconditional release of each Indemnified Party from all liability arising out of such pending or threatened proceeding and (ii) does not contain any factual or legal admission by or with respect to any Indemnified Party or any adverse statement with respect to the character, professionalism, expertise or reputation of any Indemnified Party or any action or inaction of any Indemnified Party.

In order to provide for just and equitable contribution in any case in which (i) an Indemnified Party is entitled to indemnification pursuant to this Engagement Agreement but it is judicially determined by the entry of a final judgment decree by a court of competent jurisdiction (and the time to appeal has expired or the last right of appeal has been denied) that such indemnification may not be enforced in such case as to the full extent of the Claims, or (ii) contribution may be required by the Indemnifying Party in circumstances for which an Indemnified Party is otherwise entitled to indemnification under this Engagement Agreement, then, and in each such case,. the Indemnifying Party shall contribute to the Claims in an amount, in addition to the amount for which indemnification was held available, and in such proportion as is appropriate to reflect the relative benefits to the Indemnifying Party and/or its stockholders on the one hand, and the Indemnified Party on the other hand, in connection with the matters covered by this Engagement Agreement or, if the foregoing allocation is not permitted by applicable law, not only to reflect such relative benefits but also to reflect the relative faults of such parties as well as any other relevant equitable considerations. The Indemnifying Party agrees that for purposes of this paragraph, the relative benefits to the Indemnifying Party and/or its stockholders and the Indemnified Party in connection with the matters covered by this Engagement Agreement shall be deemed to be in the same proportion that the total value paid or received or to be paid or received by the Indemnifying Party and/or its stockholders in connection with the transactions contemplated by this Engagement Agreement, whether or not consummated, bears to the fees to be paid to the Indemnified Party under this Engagement Agreement; provided, that in no event will the total contribution of each respective Indemnified Parties to all such Damages exceed the amount of fees actually received and retained by such Indemnified Party under this Engagement Agreement (excluding any amounts received by such Indemnified Party as reimbursement of expenses). Relative fault shall be determined by reference to, among other things, whether any alleged untrue statement or omission or any alleged conduct relates to information provided by the Indemnifying Party or other conduct by the Indemnifying Party (or its employees or other agents) on the one hand, or by the Indemnified Party, on the other hand. Notwithstanding the foregoing, each respective Indemnified Party shall not be obligated to contribute any amount hereunder that exceeds the amount of fees previously received by such Indemnified Party pursuant to this Engagement Agreement.

The indemnity, reimbursement, and contribution obligations of the Indemnifying Party set forth herein shall be in addition to any liability which the Indemnifying Party may otherwise have and shall be binding upon any successors, assigns, heirs, and personal representatives of the Indemnifying Party and inure to the benefit of any successors, assigns, heirs and personal representatives of an Indemnified Party.

The indemnity, reimbursement, and contribution provisions set forth herein shall remain operative and in full force and effect regardless of (i) any withdrawal, Termination or consummation of or failure to initiate or consummate any transaction contemplated by this Engagement Agreement; (ii) any investigation made by or on behalf of any party hereto or any person controlling (within the meaning of Section 15 of the Act or Section 20 of the Exchange Act) any party hereto; (iii) any termination or the completion or expiration of this Engagement Agreement; and (iv) whether or not either Party shall, or shall not be called upon to, render any formal or informal advice in the course of such engagement.

Unless otherwise defined, capitalized terms used herein shall have the meaning ascribed to them in this Engagement Agreement.